An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, ...
Jun 14, 2024
0
35
Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels ...
Mar 16, 2024
0
48
Combining targeted radiation therapy with a neutrophil stimulant enhances anti-tumor immunity, according to new research into cancer immunology at UT Southwestern Medical Center.
Sep 22, 2016
0
44
Researchers and clinicians have been working to use focused ultrasound combined with microbubbles to open the blood-brain barrier (BBB) for both noninvasive diagnostic use as well as to deliver treatments to the brain for ...
Feb 22, 2022
0
58
(HealthDay)—For patients with cancer, financial concerns are associated with psychological factors that may impact their quality of decision making regarding clinical trials, according to research published online Dec. ...
Dec 29, 2015
0
13
While there is an expectation that newer medical practices improve the standard of care, the history of medicine reveals many instances in which this has not been the case. Reversal of established medical practice occurs ...
Jul 22, 2013
0
4
(HealthDay)—People who enjoy a glass of orange juice or some fresh grapefruit in the morning may face a slightly increased risk of melanoma—the least common but most deadly form of skin cancer.
Jun 30, 2015
0
65
Chemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer—the ...
Jun 1, 2023
0
2
It took a white lie to get David Polisini, 79, to a doctor in 2004, after months of being unable to swallow.
Mar 18, 2016
0
1
A chemotherapy regimen consisting of procarbazine, CCNU, and vincristine (PCV) administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade gliomas, a form of brain ...
Nov 16, 2014
0
0
